Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

SN-38 overcomes chemoresistance of colorectal cancer cells induced by hypoxia, through HIF1alpha.

Murono K, Tsuno NH, Kawai K, Sasaki K, Hongo K, Kaneko M, Hiyoshi M, Tada N, Nirei T, Sunami E, Takahashi K, Kitayama J.

Anticancer Res. 2012 Mar;32(3):865-72.

PMID:
22399605
2.
3.

Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.

Grivicich I, Mans DR, Peters GJ, Schwartsmann G.

Braz J Med Biol Res. 2001 Sep;34(9):1087-103. Review.

4.

Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategies.

Crea F, Nobili S, Paolicchi E, Perrone G, Napoli C, Landini I, Danesi R, Mini E.

Drug Resist Updat. 2011 Dec;14(6):280-96. doi: 10.1016/j.drup.2011.08.001. Epub 2011 Sep 28. Review.

PMID:
21955833

Supplemental Content

Support Center